Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jeremy B Provance"'
Autor:
Kim G. Smolderen, Gaëlle Romain, Jeremy B. Provance, Lindsey E. Scierka, Jialin Mao, Phillip P. Goodney, Peter K. Henke, Art Sedrakyan, Carlos Mena-Hurtado
Publikováno v:
JACC: Cardiovascular Interventions. 16:332-343
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::716a57fac163bb54fe343ef5cff1da16
https://doi.org/10.1016/j.jcin.2022.09.022
https://doi.org/10.1016/j.jcin.2022.09.022
Autor:
Jeremy B Provance, John A Spertus, Philip G Jones, Mark A Hoffman, Matthew C Bunte, Todd R Vogel, Carlos Mena-Hurtado, Kim G Smolderen
Publikováno v:
Vascular medicine (London, England). 27(4)
Introduction: Patients with critical limb ischemia (CLI) can undergo endovascular peripheral vascular intervention (PVI) to restore blood flow and decrease risk of amputation. As a potential indicator of quality for CLI care, we sought to describe 30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc2803b142455a4a3e49c71db1ac36b2
https://pubmed.ncbi.nlm.nih.gov/36475949
https://pubmed.ncbi.nlm.nih.gov/36475949
Autor:
Anand Brahmandam, Megan Lee, Kirthi Bellamkonda, Jeremy B. Provance, Bauer Sumpio, Cassius Iyad Ochoa Chaar, Kim G. Smolderen, Carlos Mena-Hurtado, Raul J. Guzman
Publikováno v:
Annals of vascular surgery. 88
Antiplatelet monotherapy is recommended after infrainguinal lower extremity bypass (LEB). However, there is a paucity of high-quality data to guide therapy, and antiplatelet therapy is often prescribed in combination with anticoagulation. We therefor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e78c3d89567769a6e1b643eb56ec38c7
https://pubmed.ncbi.nlm.nih.gov/36245106
https://pubmed.ncbi.nlm.nih.gov/36245106
Autor:
Jeremy B Provance, Kim G Smolderen, Jialin Mao, Philip P Goodney, Peter Henke, Art Sedrakyan, Pragati Bogra, Carlos Mena-hurtado
Publikováno v:
Circulation. 144
Introduction: Guideline directed medical therapy (GDMT) for patients with peripheral artery disease (PAD) includes statin, antiplatelet, ACE inhibitors (angiotensin converting enzyme inhibitors) and ARBs (angiotensin-receptor blockers) therapy if hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd9435d109956473a32178a150acc344
https://doi.org/10.1161/circ.144.suppl_1.11211
https://doi.org/10.1161/circ.144.suppl_1.11211
Autor:
Laith A Derbas, Qurat-ul-ain Jelani, Sameer Nagpal, Carlos Mena-Hurtado, Jeremy B Provance, Matthew Pichert, Ali O. Malik, Eric A. Secemsky, Jiaming Huang, Yulanka Castro-Dominguez, Kim G. Smolderen
Publikováno v:
Vascular medicine (London, England). 27(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dd7c0a4d599cb473d830bce3335fb19
https://pubmed.ncbi.nlm.nih.gov/34610776
https://pubmed.ncbi.nlm.nih.gov/34610776
Publikováno v:
Diabetes. 70
Introduction: Nearly 50% of patients with diabetes and foot ulcers have concurrent peripheral artery disease (PAD), which increases risk of amputation events. These patients have a 5-year mortality rate of over 50% after lower extremity amputation. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7db341e1c9d553a4634e1fe0551f89cf
https://doi.org/10.2337/db21-1053-p
https://doi.org/10.2337/db21-1053-p
Publikováno v:
Circulation. Cardiovascular quality and outcomes. 12(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c70cb82a571560b19b2b42bc22e24639
https://pubmed.ncbi.nlm.nih.gov/31412733
https://pubmed.ncbi.nlm.nih.gov/31412733